CA 125 and other tumor markers in uterine leiomyomas and their association with lesion characteristics.
article
OA: green
CC0
⤵ 7 in-corpus citations
AI-generated summary
This study found that CA 125 levels in uterine leiomyoma patients were significantly elevated with larger myoma size and the presence of adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The aim of this study was to investigate the factors associated with serum levels of several tumor markers in a group of patients operated for uterine myoma. One hundred thirty-seven female patients operated for uterine myoma were included. Serum samples were examined for CA 125, CA 19-9, CA 15-3, carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) levels as part of routine workup. Pathological and morphological characteristics of the patients were retrieved from medical records. The mean age was 46.7 ± 8.8 years (range, 22-85 y). Abnormally high levels of CA 125, CA 19-9, CA 15-3, CEA, and AFP were found in 19.7%, 6.6%, 5.1%, 3.7%, and 1.5% of the patients, respectively. Patients with additional adenomyosis and patients with at least one large myoma (≥ 5 cm diameter) had significantly higher levels of CA 125. Multivariate analysis identified coexistence of adenomyosis (OR 7.7 [95% CI, 2.6-23.0], p < 0.001) and presence of at least one large myoma (OR 5.6 [1.4-22.8], p = 0.016) as independent predictors of abnormally high CA 125 levels. CA 125 levels are affected by the tumor size and coexistence of adenomyosis in uterine leiomyomas. Indirect mechanisms caused by large myoma size such as peritoneal irritation may be responsible for CA 125 elevations.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- [Differential diagnosis between leiomyomata uteri and adenomyosis using CA 125 as a new tumor marker of ovarian carcinoma]. via openalex
- Elevation of CA 19‐9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis via openalex
- Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis via openalex
- Peripheral CA 125 levels in patients with uterine fibroids via openalex
- Serum CA 125 concentrations in women with endometriosis or uterine fibroids treated with gonadotrophin-releasing hormone agonist analogues. via openalex
- The effect of hysterectomy on serum CA 125 levels in patients with adenomyosis and uterine fibroids via openalex
- [The value of serum CA125 assays in the diagnosis of uterine adenomyosis]. via openalex
- W2058484951 via openalex
- W2067737147 via openalex
- W2068249243 via openalex
- W2109250923 via openalex
- W2117275438 via openalex
- W2162726808 via openalex
- W2171266686 via openalex
- W2418330216 via openalex
- W136891545 via openalex
- W2473403213 via openalex
- W181204890 via openalex
- W1979384148 via openalex
- W2046284821 via openalex
- W2052404674 via openalex
- W2053169082 via openalex
- W2056257742 via openalex
Cited by (7)
- Validation of an In Vitro Diagnostic Test for Endometriosis: Impact of Confounding Medical Conditions and Lesion Location 2024
- Value of serum muscular creatinine phosphokinase levels in patients with adenomyosis as a non‐invasive diagnostic marker 2024
- Stroke in Patients With Common Noncancerous Gynecologic Diseases 2023
- The Clinical Features and Diagnosis of Adenomyosis 2021
- An enormous pelvic tumor in a 46-year-old woman with an elevated serum CA 125 level, what lies beneath it? Investigation of uterine tumors in postmenopausal women 2021
- Cerebral infarction associated with benign mucin-producing adenomyosis: report of two cases 2018
- Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma 2014
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:18:22.440000+00:00
License: CC0
· commercial use OK